muscular dystrophy - Articles and news items

FDA grants Santhera $246,000 for muscular dystrophy trial

Industry news / 30 August 2016 / Niamh Louise Marriott, Digital Content Producer

The FDA have granted Santhera an award of $246,000 in support of its ongoing Phase I trial with omigapil (callisto) incongenital muscular dystrophy (CMD)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+